Home › ISIS Pharmaceuticals: Another Entry Point
 

Keywords :   


ISIS Pharmaceuticals: Another Entry Point

2015-07-28 21:37:55| Chemicals - Topix.net

Like most biotech companies with little-to-no product revenue stream, the stock is quite volatile and driven largely by news flow. The company also benefits from several large pharmaceutical partners including J&J, Biogen Idec, Glaxo Smith Kline, Bayer, and Astra Zeneca.

Tags: point entry pharmaceuticals isis

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »